Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Similar documents
Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

I have no financial disclosures

Advanced Imaging MRI and CTA

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

Cardiac CT Angiography

Cardiac Imaging Tests

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

The use of Cardiac CT and MRI in Clinical Practice

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

Imaging of the Heart Todd Tessendorf MD FACC

General Cardiovascular Magnetic Resonance Imaging

CHRONIC CAD DIAGNOSIS

Rational use of imaging for viability evaluation

The Value of Stress MRI in Evaluation of Myocardial Ischemia

J. Schwitter, MD, FESC Section of Cardiology

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA)

Cardiac MRI: Cardiomyopathy

CMR stress Perfusion: what's new?

Cardiac CT and MRI. Ashraf Hamdan, MD. Sheba Medical Center. Sheba Medical Center Tel Hashomer. Leviev Heart Center

CASE from South Korea

MRI ACS-ben. Tamás Simor MD, PhD, Med Hab. University of Pécs, Heart Institute

Diagnosis of CAD S Richard Underwood

ORIGINAL ARTICLE. Iulia Heinle 1,*, Andre Conradie 2 and Frank Heinle 1

Potential recommendations for CT coronary angiography in athletes

Cardiac CT Lowering the Dose Dramatically

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

Current and Future Imaging Trends in Risk Stratification for CAD

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

Cardiovascular Imaging Stress Echo

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

Computer Aided Detection and Diagnosis: Cardiac Imaging Applications

Pearls & Pitfalls in nuclear cardiology

Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment

Subha V. Raman, MD, MSEE, FACC, FAHA

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Pushing the limits of cardiac CT. Steven Dymarkowski Radiology / Medical Imaging Research Centre

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Calcium scoring Clinical and prognostic value

Imaging and heart failure

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Cardiac MRI: Clinical Application to Disease

Cardiac MR Cardiac CT

Diagnostic and Prognostic Value of Coronary Ca Score

Coronary Artery Anomalies from Birth to Adulthood; the Role of CT Coronary Angiography in Sudden Cardiac Death Screening

Radiologic Assessment of Myocardial Viability

Noncoronary Cardiac MDCT

Disclosure Information

Fellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference.

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Assessment Of Myocardial Viability

CARDIAC MULTIMODALITY IMAGING: Informing better decisions - or just costly pictures?

Fulfilling the Promise

Introduction. Cardiac Imaging Modalities MRI. Overview. MRI (Continued) MRI (Continued) Arnaud Bistoquet 12/19/03

Dr Felix Keng. Imaging of the heart is technically difficult because: Role of Cardiac MSCT. Current: Cardiac Motion Respiratory Motion

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

ECG Workshop. Nezar Amir

Current Indications for Cardiac MRI: What You See is What You Get?

Is computed tomography angiography really useful in. of coronary artery disease?

Dual Energy CT of the Heart: Perfusion and Beyond

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Horizon Scanning Technology Summary. Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease

12 Lead ECG Interpretation

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

MR Assessment of Myocardial Viability

Raja Muthupillai, PhD. Department of Diagnostic and Interventional Radiology St. Luke s Episcopal Hospital. Research Support: Philips Healthcare

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Viability Testing Using Dynamic Echocardiography

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

Case based learning: CMR in Heart Failure

Assessment of Ischemia and Viability

Getting the Most Out of Stress Echo

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Cardiac MRI: Appropriateness. Scott Mattson, DO, FACC Lutheran Medical Group Fort Wayne, IN

The Emerging Role of Cardiac CT in Cardiovascular Imaging. Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016

Common Codes for ICD-10

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

CT or PET/CT for coronary artery disease

Imaging of Coronary Artery Disease: II

Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: State-of-the-Art Updates and 101 Evidence-Based Case Reviews

Conflict of Interest Disclosure

Correlation of Cardiac CTA to Conventional Cardiac Angiography in Diagnosing Coronary Artery Stenosis in a Community Based Center

CARDIAC MRI. Cardiovascular Disease. Cardiovascular Disease. Cardiovascular Disease. Overview

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Atypical pain and normal exercise test

Calcium Scoring and Cardiac CT

Myocardial viability testing. What we knew and what is new

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

SPECT CT Current Status and Future Direction Nuclear Cardiology

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

HEART CONDITIONS IN SPORT

Transcription:

GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September Disclosures None relevant to this presentation Mini Pakkal Assistant Professor of Radiology University Hospital Network Toronto mini.pakkal@uhn.ca Overview Overview of the relevant concepts of various cardiac imaging modalities Spatial Time of acquisition Anatomical vs functional imaging Exploit the strengths of the various cardiac modalities to answer specific clinical questions Select examples Imaging modalities 1

Coronary CT angiogram Coronary MR angiogram MRCA vs. MDCT Meta-analysis Search until June 09 89 MDCT studies (7516 patients) 20 MRCA studies (989 patients) 1 study at 3T 5 head to head comparisons (325 patients) QCA 50% diameter stenoses Sensitivity Specificity AUC MDCT 97% (96-98%) 87% (84-90%) 98% (96-99%) MRCA 87% (83-90%) 70% (60-79%) 89% (86-91%) Schuetz et al. Ann Intern Med 2010 Proximal stenoses 1.5T Non- targeted SSFP 64 Slice MDCT MRA CT MRA + 30 patients CT Sensitivit 85% 83% 92% y Specificit 87% 87% 92% y NPV 60% 59% 72% PPV 96% 97% 98% Accuracy 87% 86% 94% Cheng et al. IJC 2013 Anomalous coronary artery origins Calcified Plaques 27 patients with at least 1 calcified plaque with a calcium score >100 (33 plaques) 1.5T vs. 64 Slice (Targeted 3D and Whole Heart with a 8 or 6 element coil) MRI MDCT P Sensitivity 0.81 0.75 0.56 Specificity 0.75 0.48 0.002 ROC Area 0.83 0.65 0.03 ACCF/ACR/AHA/NASCI/SCMR Expert Consensus document Circ 2010 Liu et al. AJR 2007 2

- Summary MR vs CT Spatial of MR is 1-2 mm, CT is 0.4-0.6 mm CT better than MR for coronary artery stenosis >=50 % 30 %-50 % of segments cannot be evaluated Takes longer (mins vs msec) Best for proximal and mid segments No radiation exposure No No blooming artefact from calcium CT coronary artery atherosclerosis MR anomalous origins, aneurysms Spatial of MR vs Nuclear (SPECT) MR Impact II trial 33 centres, 465 patients Stenosis >50% AUC CMR =0.75 AUC Spect =0.65 CMR consistently detected more subendocardial perfusion defects and infarcts than SPECT Time to acquire data for image shutter speed Moving object requires fast shutter speed and short time window to acquire the image The heart is a moving target Mean Translational Motion LAD 22.4 mm/s ± 4 RCA 69.5 mm/s ± 22 CX 48.4 mm/s ± 15 Normal coronary artery between 2-5mm Achenbach, Radiology 2000 Courtesy: Sue Edyvean 3

Conventional angio is superior to cardiac CT (better spatial and temporal ) Modern CT scanners handle higher heart rates well and MR are superior to CT for assessment of moving structures such as valves better than MR for assessment of valvular and subvalvular structures e.g. mitral valve Mitral valve Functional vs anatomical imaging in CAD Anatomical description of stenosis <50% stenosis = mild 50-69% stenosis = moderate >=70% stenosis = severe What does it mean? Gould and Lipscomb, 1974 found that stenosis of <50% less likely to be functionally significant Basic principle of investigation of choice ANATOMICAL AND FUNCTIONAL IMAGING Fame substudy 2010 Stenosis severity %Functionally significant %Functionally non significant 50-70% 35% 65% 71-90% 80% 20% 91-99% 96% 4% A 50-70% stenosis can be signficant Length and number of stenosis Proximal stenosis subtend a larger area Increased oxygen consumption e.g. left ventricular hypertrophy Decreased arterial oxygen saturation e.g anaemia Case 1 55 yr F Atypical Chest pain 4

Case 2 Case 2 47 yr M, Asian Atypical Chest pain Smoker CACS=26 Next step: CCTA Case 3 Case 3 45 yr M Atypical Chest pain No risk factors CAC = 151 Spatial of MR vs Nuclear (SPECT) MR Impact II trial 33 centres, 465 patients Stenosis >50% AUC CMR =0.75 AUC Spect =0.65 CMR consistently detected more subendocardial perfusion defects and infarcts than SPECT Attenuation Artefact Heart surrounded by varying amounts of attenuation material tissue bone and lung. Attenuation different between males and females Male Diaphragm attenuation Female Breast attenuation LV LV Causes inferior wall artefact Causes anterior wall artefact 5

Gut activity adjacent to the inferior wall Perfusion defects MR vs SPECT Radiation issues - 8mSv (4mSv for stress and rest each) Large patients Left main stem and three vessel disease false negative with SPECT scans LBBB Throughput through the MR scanner/reporting time Renal dysfunction Triaging mechanism - What about stress echocardiography Based on demonstrating contractile reserve rather than vasodilatory reserve Is more specific as systolic dysfunction occurs much later in the ischaemic cascade Low sensitivity (26%) in severe left ventricular dysfunction due to impairment of ionotropic reserve 6

Viable Myocardium Acute MI Scar Transmurality of infarct Intact cell membranes [] = Low Ruptured cell membranes [] = High Collagen matrix [] = High im RJ, Choi M, Judd RM. In Cardiovascular MRI and MRA, Higgins and DeRoos editors im 2000 - viability 0%: 78% of segments with no DE showed good functional recovery. 1-25%: 60% of segments showed functional recovery 26-50%: 42% of segments showed functional recovery 51-75%: 10% of segments showed functional recovery >75%: 2% of segments recovered Subendocardial infarct Infarction delayed enhancement Case 1 35 year old with chest pain Raised troponins Normal coronary angiogram 7

Myocarditis Case 2 28 year old Presented with multiple episodes of syncope and palpitations 2:1 heart block on ECG Sarcoidosis Case 3 65 year old Hypertension Presented with CCF slow response showed concentric hypertrophy 8

ECG Amyloidosis Summary What is the functional significance of the anatomical abnormality I am seeing? with delayed enhancement subendocardial vs non subendocardial Acknowledgment Course organisers Ben Ariff and Su Edyvean The cardiothoracic imaging divisions in JDMI and Toronto 9